Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 9314399)

Published in J Bone Joint Surg Am on September 01, 1997

Authors

C W Francis1, V D Pellegrini, S Totterman, A D Boyd, V J Marder, K M Liebert, B N Stulberg, D C Ayers, A Rosenberg, C Kessler, N A Johanson

Author Affiliations

1: Vascular Medicine Unit, University of Rochester School of Medicine, New York 14642, USA.

Articles citing this

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 3.08

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res (2008) 1.82

Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. J Vasc Surg (2012) 1.63

Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg (2009) 1.18

Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study. Postgrad Med J (2006) 1.15

Duplex ultrasonography after total hip or knee arthroplasty. Int Orthop (2003) 0.90

Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis. Clin Orthop Relat Res (2012) 0.88

Thromboembolic prophylaxis in total joint arthroplasty. Thrombosis (2012) 0.87

Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty? Clin Orthop Relat Res (2014) 0.83

Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial. J Thorac Dis (2015) 0.79

Prolonged use of thromboprophylaxis may not be necessary in laparoscopic colorectal surgery. Int J Colorectal Dis (2011) 0.78

Thromboprophylaxis and orthopaedic surgery: options and current guidelines. Malays J Med Sci (2014) 0.78

Effects of antithrombotic drugs fondaparinux and tinzaparin on in vitro proliferation and osteogenic and chondrogenic differentiation of bone-derived mesenchymal stem cells. J Orthop Res (2011) 0.78

Effect of a direct thrombin inhibitor compared with dalteparin and unfractionated heparin on human osteoblasts. Open Orthop J (2011) 0.76

Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement. Thromb J (2012) 0.75

Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model. PLoS One (2016) 0.75

50 years ago in CORR: Postspinal anesthesia osteomyelitis of the lumbar spine P. L. Day MD and J. J. Hinchey MD CORR 1958;11:185-193. Clin Orthop Relat Res (2008) 0.75

Comparison of postoperative complications after total hip arthroplasty among patients receiving aspirin, enoxaparin, warfarin, and factor Xa inhibitors. J Orthop (2017) 0.75

Articles by these authors

The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48

Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol (1982) 4.08

Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med (1997) 3.53

Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24

Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed (2001) 3.17

Recognition sequences of restriction endonucleases and methylases--a review. Gene (1985) 3.08

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet (1993) 3.03

Treatment of AIDS-related bronchopleural fistula by pleurectomy. Ann Thorac Surg (1992) 2.88

Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell (1986) 2.85

Patients' expectations and satisfaction with total hip arthroplasty. J Arthroplasty (1997) 2.52

Biopsy: complicated and risky. J Bone Joint Surg Am (1996) 2.42

Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem (1991) 2.39

Specificity of restriction endonucleases and methylases--a review. Gene (1986) 2.37

Surgical management of basal joint arthritis of the thumb. Part II. Ligament reconstruction with tendon interposition arthroplasty. J Hand Surg Am (1986) 2.31

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31

Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthritis Cartilage (2006) 2.29

Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA (1992) 2.27

Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. J Lab Clin Med (1992) 2.22

beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis. J Infect Dis (1987) 2.17

Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol (1992) 2.13

Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol (1984) 2.13

High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem (1969) 2.09

Geographic variations in the rates of elective total hip and knee arthroplasties among Medicare beneficiaries in the United States. J Bone Joint Surg Am (1992) 2.04

Indications for total hip and total knee arthroplasties. Results of orthopaedic surveys. J Arthroplasty (1996) 2.00

Change in cartilage morphometry: a sample of the progression cohort of the Osteoarthritis Initiative. Ann Rheum Dis (2008) 1.98

Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1. Ann Intern Med (1993) 1.97

Rate of degeneration of human acetabular cartilage after hemiarthroplasty. J Bone Joint Surg Am (1995) 1.93

NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci U S A (1998) 1.92

Ultrasound surveillance for asymptomatic deep venous thrombosis after total joint replacement. J Bone Joint Surg Am (1998) 1.82

Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty (1998) 1.82

Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. J Biol Chem (1983) 1.77

Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest (1985) 1.76

Arthroplasty of the basal joint of the thumb. Long-term follow-up after ligament reconstruction with tendon interposition. J Bone Joint Surg Am (1995) 1.69

Safety and efficacy of the antiseptic chlorhexidine gluconate. Surg Gynecol Obstet (1976) 1.67

Heterotopic ossification following primary total knee arthroplasty. J Arthroplasty (1995) 1.65

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64

Prevalence of ocular hemorrhage in patients receiving warfarin therapy. Can J Ophthalmol (2000) 1.62

Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am (1984) 1.61

Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg Am (2000) 1.61

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60

Ageusia as an adverse effect of phenytoin treatment. Lancet (1998) 1.59

A prospective study of complications of pulmonary artery catheterizations in 500 consecutive patients. Chest (1983) 1.56

Extrapelvic compression of the sciatic nerve. An unusual cause of pain about the hip: report of five cases. J Bone Joint Surg Am (1992) 1.54

Cloning, characterization and heterologous expression of the SmaI restriction-modification system. Nucleic Acids Res (1989) 1.52

Non-radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA-based detection. Nucleic Acids Res (1990) 1.52

Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol (1993) 1.51

Enhancement of BOLD-contrast sensitivity by single-shot multi-echo functional MR imaging. Magn Reson Med (1999) 1.48

Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47

Nerve injury in total hip arthroplasty. Clin Orthop Relat Res (1983) 1.46

Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood (1993) 1.46

Lack of evidence for the involvement of a beta-D-galactosyl-specific lectin in the fusion of chick myoblasts. Biochem Biophys Res Commun (1976) 1.45

Tensile strength of the cement-bone interface depends on the amount of bone interdigitated with PMMA cement. J Biomech (1997) 1.45

Gorham's massive osteolysis: the role of radiation therapy and a review of the literature. Int J Radiat Oncol Biol Phys (1993) 1.43

Radiation prophylaxis of heterotopic ossification. Int J Radiat Oncol Biol Phys (1994) 1.42

Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies. Am J Med (1971) 1.41

Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest (1992) 1.41

Simulated Bennett fracture treated with closed reduction and percutaneous pinning. A biomechanical analysis of residual incongruity of the joint. J Bone Joint Surg Am (1997) 1.40

Water catalysis of peptide hydrogen isotope exchange. Biochemistry (1983) 1.40

Acquired "storage pool disease" of platelets associated with circulating antiplatelet antibodies. Am J Med (1974) 1.40

Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. AJR Am J Roentgenol (1990) 1.39

[Evaluation of stroke units as medical technology]. Nervenarzt (2001) 1.39

Deep venous thrombosis following total hip arthroplasty. Effects of prolonged postoperative epidural anesthesia. J Arthroplasty (1994) 1.39

Three new restriction endonucleases MaeI, MaeII and MaeIII from Methanococcus aeolicus. Nucleic Acids Res (1984) 1.39

Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38

Unusual anemias. Am J Hematol (1997) 1.38

Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J Virol (1999) 1.38

Fat embolism syndrome: a review of the pathophysiology and physiological basis of treatment. Clin Orthop Relat Res (1982) 1.38

Ksp632I, a novel class-IIS restriction endonuclease from Kluyvera sp. strain 632 with the asymmetric hexanucleotide recognition sequence: 5'-CTCTTC(N)1-3' 3'-GAGAAG(N)4-5'. Gene (1988) 1.36

Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol (2001) 1.35

The acutely ACL injured knee assessed by MRI: changes in joint fluid, bone marrow lesions, and cartilage during the first year. Osteoarthritis Cartilage (2008) 1.34

Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. J Cell Biol (1986) 1.34

The size of human factor VIII heterodimers and the effects produced by thrombin. Biochim Biophys Acta (1986) 1.31

Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol (1988) 1.29

Differential amygdala activation in schizophrenia during sadness. Schizophr Res (1998) 1.29

Microbial cleavage of various organophosphorus insecticides. Appl Environ Microbiol (1979) 1.28

Cloning, expression and characterization of the Sau3AI restriction and modification genes in Staphylococcus carnosus TM300. Gene (1990) 1.28

High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. J Biol Chem (1969) 1.28

Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplasty (1991) 1.28

Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci (1965) 1.27

Effect of age on muscle hypertrophy induced by resistance training. J Gerontol A Biol Sci Med Sci (1996) 1.27

A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg (1994) 1.26

Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med (1977) 1.26

Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol (2000) 1.25

von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood (1987) 1.25

Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma (2005) 1.23

Relationship between the lateral acromion angle and rotator cuff disease. J Shoulder Elbow Surg (1996) 1.23

Forkhead transcription factor FOXO1A is critical for induction of human decidualization. J Endocrinol (2006) 1.19

The solvent dependence of hydrogen exchange kinetics of folded proteins. J Biol Chem (1975) 1.19

Mediastinitis following open-heart surgery. Review of two years' experience. Arch Surg (1973) 1.19

Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity. Blood (1980) 1.18

Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection. Ann Intern Med (1986) 1.17

Pressure effects on folded proteins in solution. Hydrogen exchange at elevated pressures. J Biol Chem (1978) 1.16

Esophagogastrostomy. Analysis of 55 cases. J Thorac Cardiovasc Surg (1975) 1.15

Sensitive chemiluminescent detection of digoxigenin-labeled nucleic acids: a fast and simple protocol and its applications. Biotechniques (1992) 1.14

In situ hybridization with digoxigenin-labeled DNA of human papillomaviruses (HPV 16/18) in HeLa and SiHa cells. Biotechniques (1990) 1.14

Comparative evaluation of surgical scrub preparations. Surg Gynecol Obstet (1978) 1.14

The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med (1979) 1.14